BioCentury
ARTICLE | Financial News

Atlas closes $280M life sciences-only fund

April 18, 2015 12:53 AM UTC

Atlas Venture closed its oversubscribed $280 million Atlas Fund X, the firm's first fund since becoming an exclusively life sciences-focused VC.

Formerly a hybrid firm, Atlas separated its tech and life sciences teams last October, citing diverging ecosystems and business models. The healthcare team retained the Atlas name (see BioCentury, Oct. 6, 2014). ...